Thursday, 9 October 2008
Abbott Ludwigshafen – Lecture Hall Building 11
|
|
|
08:00 – 09:00
|
Arrival, Registration, and Breakfast
|
|
|
09:00 – 09:15
|
Welcome Address
Dr Jörg Breitenbach, Head of SOLIQS, Ludwigshafen, Germany
|
|
|
09:15 – 10:00
|
Compound Suitability and Formulation Stability of Amorphous Dosage Forms
Prof Dr Lian Yu, University of Wisconsin–Madison, USA
|
|
|
10:00 – 10:45
|
Polymers for Pharmaceutical Melt Extrusion—Formulation, Process, and Regulatory
Aspects
Dr Karl Kolter, BASF SE, Ludwigshafen, Germany
|
|
|
10:45 – 11:00
|
Break
|
|
|
11:00 – 11:45
|
Formulation Design of Melt-Extruded Dosage Forms
Prof Dr Jean Paul Remon, Ghent University, Belgium
|
|
|
11:45 – 12:30
|
Pharmaceutical Melt Extrusion With Twin-Screw Extruders
Dipl.-Ing Johannes Donner, Coperion Werner und Pfleiderer GmbH & Co KG, Stuttgart,
Germany
|
|
|
12:30 – 13:45
|
Meet the Experts—Networking Lunch in the Abbott Cafeteria
|
|
|
13:45 – 14:30
|
Mechanism of Bioavailability Enhancement of Solid Solutions/Solid Dispersions
Prof Dr Martin Brandl, University of Tromsø, Norway
|
|
|
14:30 – 15:15
|
In Vitro/In Vivo Relationships of Melt Extrusion Dosage Forms
Prof Dr Jennifer Dressman, Johann Wolfgang von Goethe University, Frankfurt, Germany
|
|
|
15:15 – 16:00
|
The Kaletra® Meltrex® Story: Turning Scientific Challenges
into Patient Benefit
Dr Jörg Breitenbach, Head of SOLIQS, Ludwigshafen, Germany
|
|
|
16:00 – 16:30
|
Break
|
|
|
16:30 – 18:00
|
Grand Opening of New SOLIQS Development Facilities
|
|
|
18:00
|
Ribbon Cutting Ceremony and Reception
|
|
|
19:00
|
Bus Transfer to Dinner in Heidelberg – Return to Mannheim/Ludwigshafen Approximately
23:30
Guest Dinner Speaker: Prof Dr Trevor Jones, King’s College London, England
|
|
|
|
|
Friday, 10 October 2008
Abbott Ludwigshafen – Cafeteria Building 38
|
|
|
08:00 – 11:00
|
Breakfast and Information Session with SOLIQS Experts Tour of SOLIQS/Abbott Facilities
|
|
|
Abbott Ludwigshafen – Lecture Hall Building 11
|
|
|
11:00 – 11:45
|
Melt Extrudates as Oral and Parenteral Controlled-Release Dosage Forms: Effects
of Formulation and Process Variables
Prof Dr Eric Doelker, University of Geneva, Switzerland
|
|
|
11:45 – 12:30
|
Beyond Poor Solubility: Melt Extrusion Drug Delivery Case Studies
Dr Markus Mägerlein, SOLIQS, Ludwigshafen, Germany
|
|
|
12:30 – 13:15
|
Melt-Extruded Formulations: A Clinician’s View
Prof Dr Hans-Jürgen Stellbrink, Infektionsmedizinisches Centrum, Hamburg, Germany
|
|
|
13:15
|
Closing Remarks, Lunch, and Departures
|